The Role of Percutaneous Coronary Revascularization in Advanced Ischemic Heart Disease

Modern Angioplasty and Stent Technology; Technique, Application and Efficacy, Comparison to Surgical
Chapter
First Online:

Keywords

Percutaneous Coronary Intervention Coronary Artery Bypass Grafting Stent Thrombosis Bare Metal Stent Dual Antiplatelet Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Nobel Lecture, Physics, 1901–1921, Elsevier Publishing Company, Amsterdam, 1967.Google Scholar
  2. 2.
    Cournand AF, Riley RL, Breed ES, et al. Measurement of cardiac output in man using the technique of catheterization of the right auricle. J Clin Invest 1945;24:106.PubMedCrossRefGoogle Scholar
  3. 3.
    Richard DW. Cardiac output in the catherization technique in various clinical conditions. Fed Proc 1945;4:215.Google Scholar
  4. 4.
    Nobel Lectures, Physiology or Medicine 1942–1962, Elsevier Publishing Company, Amsterdam, 1964.Google Scholar
  5. 5.
    Sones FM. Cine coronary angiography. Mod Concepts Cardiovasc Dis 1962;31:735–738.PubMedGoogle Scholar
  6. 6.
    Dotter C, Judkins MP. Transluminal treatment of arteriosclrotic obstruction: description of a new technique and preliminary report on its application. Circulation 1964;30:654.PubMedGoogle Scholar
  7. 7.
    Dotter CT, Rosch J, Anderson JM, et al. Transluninal iliac artery dilatation: nonsurgical catheter treatment of atheromatous narrowing. JAMA 1978;230:117.CrossRefGoogle Scholar
  8. 8.
    Dotter CT. Transluminal angioplasty: a long view. Radiology 1980;135:561.PubMedGoogle Scholar
  9. 9.
    Favalaro RG. Saphenous vein graft in the surgical treatment of coronary artery disease: operative technique. J Thorac Cariovasc Surg 1969;58:178.Google Scholar
  10. 10.
    Greuntzig AR, Turina MI, Schneider JA. Experimental percutaneous dilatation of coronary artery stenosis. Circulation 1976;54:81.Google Scholar
  11. 11.
    Greuntzig AR. Translumination dilatation of coronary artery stenosis. Lancet 1978;1:263.CrossRefGoogle Scholar
  12. 12.
    Simpson JB, Baim DS, Robert EW, Harrison DC. A new catheter system for coronary angioplasty. Am J Cardiol 1982;49:1216.PubMedCrossRefGoogle Scholar
  13. 13.
    Detre K, Peduzzi P, Murphy M, et al. Effect of bypass surgery on survival in patients with low and high risk subgroups delineated by use of simple clinical variable. Circulation 1981;63:1329.PubMedGoogle Scholar
  14. 14.
    Murphy ML, Hultgren HN, Detre K, et al. Treatment of chronis stable angina: a preliminary report of survival data of the randomized Veterans Administration Cooperative Study. N Engl J Med 1977;297:621.PubMedCrossRefGoogle Scholar
  15. 15.
    CASS Principal Investigators and their Associates. Myocardial infarction and mortality in the Coronary Artery Surgery Study. N Engl J Med 1984;310:750.CrossRefGoogle Scholar
  16. 16.
    Yusuf S, Zucker D, Peduzzi P, et al. Effect of coronary artery bypass surgery on survival: overview of 10 year results from randomized rials by the Coronary Artery Bypass Surgery Trialists Collaboration. Lancet 1994;344:563.PubMedCrossRefGoogle Scholar
  17. 17.
    Parisi AF, Folland ED, Hertigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. N Engl J Med 1992;326:10.PubMedCrossRefGoogle Scholar
  18. 18.
    Folland ED, Hartigan PM, Parisi AF. Percutaneous transluminal coronary angioplasty versus medical therapy for stable angina pectoris: outcomes for patients with double-vessel versus single—vessel coronary artery disease in a Vererans Affairs cooperative randomized trial. J Am Coll Cardiol 1997;29:1505.PubMedCrossRefGoogle Scholar
  19. 19.
    RITA 2 Trial Participants. Coronary angioplasty versus medical therapy for angina; The second Randomized Intervention Treatment of Angina trial. Lancer 1997;350:461.CrossRefGoogle Scholar
  20. 20.
    Hueb WA Bellotti G, de Oliveira SA, et al. The Medicine, Angioplasty and Surgery Study: a prospective, randomized trial of medical therapy, balloon angioplasty, or bypass surgery for single proximal left anterior descending artery stenosis. J Am Coll Cardiol 1995;26:606.CrossRefGoogle Scholar
  21. 21.
    RITA Trial Participants. Coronary angioplasty vs. coronary artery bypass surgery: the randomized intervention treatment of angina trial. Lancet 1993;341:573.CrossRefGoogle Scholar
  22. 22.
    Rodriguez A, Boullon F, Perez-Balino N, et al. Argentine randomized trial of percutaneous transluminal coronary angioplasty versus coronary artery bypass surgery in multivessel disease: in-hospital results and 1 year follow-up. J Am Coll Cardiol 1993;22:1060.PubMedCrossRefGoogle Scholar
  23. 23.
    Rogers WJ, Alderman EL, Chaitman BR, et al. Bypass angioplasty revasculariztion investigation: baseline clinical and angiographic data. Am J Cardiol 1995;75:9C.PubMedCrossRefGoogle Scholar
  24. 24.
    Waller BF. “Crackers, breakers, stretchers, drillers, scrapers, shavers, burners, welders and melters”—the future treatment of atherosclerotic coronary artery disease? a clinical-morphologic assessment. J Am Coll Cardiol 1989;13:969–987.PubMedCrossRefGoogle Scholar
  25. 25.
    Serruys PW, de Jaegere P, Kiemeneij F, et al., for the BENESTENT study group. A comparison of balloon-expandable stent implantation with balloon angioplasty in patients with coronary artery disease. N Engl J Med 1994;331:489–495.PubMedCrossRefGoogle Scholar
  26. 26.
    Fischman DL, Leon MB, Baim DS, et al., for the Stent Restenosis Study Investigators. A randomized comparison of coronary stent placement and balloon angioplasty in the treatment of coronary artery disease. N Engl J Med 1994;331:496–501.PubMedCrossRefGoogle Scholar
  27. 27.
    Serruys PW, Unger F, Sousa JE, et al. Comparison of coronary bypass surgery and stenting for the treatment of multivesel disease. N Engl J Med 2001;344:1117–1124.PubMedCrossRefGoogle Scholar
  28. 28.
    Serruys P, Ong A, van Herwerden L, et al. Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease. J Am Coll Cardiol 2005; 46:575–581.PubMedCrossRefGoogle Scholar
  29. 29.
    Rodriguez A, Bernardi V, Navia J, et al. Argentine randomized study: coronary angioplasty wih stenting versus coronary artery bypass surgery in patients with multiple vessel disease: 30-day and one year follow-up results. J Am Coll Cardiol 2001;37:51–58.PubMedCrossRefGoogle Scholar
  30. 30.
    Rodriguez A, Baldi J, Pereira C, et al. Five-year follow-up of the argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease. J Am Coll Cardiol 2005;46:583–588.CrossRefGoogle Scholar
  31. 31.
    Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q-wave myocardial infarction: results of the TIMI IIIB trial. Thrombolysis in myocardial ischemia. Circulation 1994;89:1545–1556.Google Scholar
  32. 32.
    Baigent C, Collins R, Appleby P, Parish S, Sleight P, Peto R, for the ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. ISIS-2: 10 year survival among patients with suspected acute myocardial infarction in randomised comparison of intravenous streptokinase, oral aspirin, both, or neither. BMJ 1998;316:1337–1343.PubMedGoogle Scholar
  33. 33.
    Franzosi MG, Santoro E, De Vita C, et al. Ten-year follow-up of the first megatrial testing thrombolytic therapy in patients with acute myocardial infarction: results of the Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto-1 study. The GISSI Investigators. Circulation 1998;98:2659–2665.PubMedGoogle Scholar
  34. 34.
    TIMI IIIB Investigators. Effects of tissue plasminogen activator and a comparison of early invasive and conservative strategies in unstable angina and non-Q wave myocardial infarction. Circulation 1994;89:1545.Google Scholar
  35. 35.
    Wallentin L, Lagerqvist B, Husted S, et al. Outcome at 1-year after an invasive compared with a non-invasive strategy in unstable coronary artery disease (FRISC-2). Lancet 2000;359:9–16.CrossRefGoogle Scholar
  36. 36.
    Boden WE, O’Rourke RA, Crawford MH, et al. Outcomes in patients with acute non-Q wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy (VANQUISH). N Engl J Med 1998;338:1785–1792.PubMedCrossRefGoogle Scholar
  37. 37.
    Cannon C, Weintraub W, Demopoulos L, et al. Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with Glycoprotein IIb/IIIa inhibitor Tirofiban. N Engl J of Med 2001;344:1879–1887.CrossRefGoogle Scholar
  38. 38.
    Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI): Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Lancet 1986;1:397– 402.Google Scholar
  39. 39.
    ISIS-2 (Second International Study of Infarct Survival) Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. Lancet 1988;2:349–360.PubMedGoogle Scholar
  40. 40.
    Meijer A, Verheugt FW, Werter CJ, Lie KI, van der Pol JM, van Eenige MJ. Aspirin versus coumadin in the prevention of reocclusion and recurrent ischemia after successful thrombolysis: a prospective placebo-controlled angiographic study. Results of the APRICOT Study. Circulation 1993;87:1524–1530.PubMedGoogle Scholar
  41. 41.
    O'Keefe JH, Jr., Rutherford BD, McConahay DR, et al. Early and late results of coronary angioplasty without antecedent thrombolytic therapy for acute myocardial infarction. Am J Cardiol 1989;64:1221–1230.PubMedCrossRefGoogle Scholar
  42. 42.
    Rothbaum DA, Linnemeier TJ, Landin RJ, et al. Emergency percutaneous transluminal coronary angioplasty in acute myocardial infarction: a 3 year experience. J Am Coll Cardiol 1987;10:264–272.PubMedCrossRefGoogle Scholar
  43. 43.
    Grines CL, Browne KF, Oneil W, et al., for the Primary Angioplasty in Myocardial Infarction study group. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. N Engl J Med 1993;328:673–679.PubMedCrossRefGoogle Scholar
  44. 44.
    Zijlstra F, de Boer M, Hoorntje J, et al. Comparison of immediate coronary angioplasty with intravenous streptokinase in myocardial infarction. N Eng J Med 1993;328:680–684.CrossRefGoogle Scholar
  45. 45.
    Cannon CP, Gibson CM, Lambrew CT. Relationship of symptom onset to balloon time and door to balloon time with the mortality in patients undergoing angioplasty for acute myocardial infarction. JAMA 2000;283:2941–2947.PubMedCrossRefGoogle Scholar
  46. 46.
    Nagakawa Y, Iwasaki Y, Kimura T, et al. Serial angiographic follow-up after successful direct angioplasty for acute myocardial infarction. Am J Cardiol 1996;78:980–984.CrossRefGoogle Scholar
  47. 47.
    Grines CL, Cox DA, Stone GW, et al. Coronary angioplasty with or without stent implantation for acute myocardial infarction. N Engl J Med 1999;341:1949–1956.PubMedCrossRefGoogle Scholar
  48. 48.
    Maillard L, Hamon M, Khalife K, et al. A comparison of systematic stenting and conventional balloon angioplasty during primary percutaneous transluminal coronary angioplasty for acute myocardial infarction. J Am Coll Cardiol 2000;35:1729–1736.PubMedCrossRefGoogle Scholar
  49. 49.
    Antoniucci D, Santoro GM, Bolognese L, et al. A clinical trial comparing primary stenting of the infarct related artery with optimal primary angioplasty for acute myocardial infarction (FRESCO). J Am Coll Cardiol 1998;31:1234–1239.PubMedCrossRefGoogle Scholar
  50. 50.
    Lefkovits J, Ivanhoe RJ, Califf RM, et al. Effects of platelet glycoprotein IIb/IIIa receptor blockade by a chimeric monoclonal antibody on acute and six-month outcomes after percutaneous transluminal coronary angioplasty for acute myocardial infarction (EPIC). Am J Cardiol 1996;77:1045–1051.PubMedCrossRefGoogle Scholar
  51. 51.
    Antman E, et al. ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-Executive summary. J Am Coll Cardiol 2004;44:671–719.PubMedCrossRefGoogle Scholar
  52. 52.
    Cutlip DE, Chauhan MS, Baim DS, et al. Clinical restenosis after coronary stenting: perspectives from multicenter trials. J Am Coll Cardiol 2002;40:2082–2089.PubMedCrossRefGoogle Scholar
  53. 53.
    Hausleiter J, Kastrati A, Mehili J, et al. Predictive factors for early cardiovascular events and angiographic restenosis after coronary stent placement in small coronary arteries. J Am Coll Cardiol 2002;40:882–889.PubMedCrossRefGoogle Scholar
  54. 54.
    Kereiakes D, Linnemeier TJ, Baim DS, et al. Usefulness of stent length in predicting in-stent restenosis (the MULTI-LINK stent trials). Am J Cardiol 2000;86:336–341.PubMedCrossRefGoogle Scholar
  55. 55.
    Marx SO, Jayaraman T, Go LO, et al. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res 1995;76:412–417.PubMedGoogle Scholar
  56. 56.
    Poon M, Marx SO, Gallo R, et al. Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest 1996;98:2277–2283.PubMedCrossRefGoogle Scholar
  57. 57.
    Morice MC, Serruys PW, Sousa E, et al. A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization. NEJM 2002;346:1773–1780.PubMedCrossRefGoogle Scholar
  58. 58.
    Surruys PW, Degertekin M, Tanabe K, et al. Intravascular ultrasound findings in the multicenter randomized, double-blind RAVEL trial. Circulation 2002;106:798–803.CrossRefGoogle Scholar
  59. 59.
    Kobayashi Y, Honda Y, Christie LG, et al. Long-term vessel response to a self-expanding coronary stent: a serial volumetric intravascular ultrasound analysis from the ASSURE trial. J Am Coll Cardiol 2001; 1329–1334.Google Scholar
  60. 60.
    Uren NG, Schwarzacher SP, Metz JA, et al. Predictors and outcomes of stent thrombosis: an intrazvascular ultrasound registry. Eur Heart J 2002;23:124–132.PubMedCrossRefGoogle Scholar
  61. 61.
    Holmes DR Jr, Leon MB, Moses JW, Popma JJ, Cutlip D, Fitzgerald PJ, Brown C, Fischell T, Wong SC, Midei M, Snead D, Kuntz RE. Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis. Circulation. 2004 Feb 10;109(5):634–40.Google Scholar
  62. 62.
    Moses J, Leon M, Popma J, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003;349:1315–1323.PubMedCrossRefGoogle Scholar
  63. 63.
    Axel DI, Kunert W, Goggelmann C, et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 1997;96:636–645.PubMedGoogle Scholar
  64. 64.
    Hanke H, Oberhoff M, Hanke S, Hassenstein S, Kamenz J, Schmid KM, Betz E, Karsch KR. Inhibition of cellular proliferation after experimental balloon angioplasty by low-molecular-weight heparin. Circulation 1992;85:1548–1556.PubMedGoogle Scholar
  65. 65.
    Schwartz RS, Holmes DR, Topol EJ. The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol 1992;20:1284–1293.PubMedCrossRefGoogle Scholar
  66. 66.
    Grube E, Silber S, Hauptmann KE, et al. Six and twelve-month results from a randomized, double blind tial on a slow-release Paclitaxel-eluting stent for de novo coronary lesion. Circulation 2003;107:38–42.PubMedCrossRefGoogle Scholar
  67. 67.
    Stone G, Ellis S, Cox D, et al. A polymer-based, Paclitaxel-eluting stent in patients with coronary artery disease. N Eng J Med 2004;350:221–231.CrossRefGoogle Scholar
  68. 68.
    Joner M, Finn AV, Farb A, et al. Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk. J Am Coll Cardiol 2006;48:193–202.PubMedCrossRefGoogle Scholar
  69. 69.
    McFadden EP, Stabile E, Regar E, et al. Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy. Lancet 2004;364:1519–1521.PubMedCrossRefGoogle Scholar
  70. 70.
    Camenzind E. Do drug-eluting stent increase death? ESC Congress News. Barcelona, Spain; 2006.Google Scholar
  71. 71.
    Lagerqvist B, James SK, Stenestrand U, Lindbäck J, Nilsson T, Wallentin L, SCAAR Study Group. Long-term outcomes with drug-eluting stents versus bare-metal stents in Sweden. N Engl J Med 2007 Mar 8;356(10):1009–1019PubMedCrossRefGoogle Scholar
  72. 72.
    US Food and Drug Administration. Circulatory System Devices Panel. Available at http://www.fda.gov/ohrms/dockets/ac/cdrh06.html#circulatory
  73. 73.
    William HM. Unanswered questions—drug-eluting stents and the risk of late thrombosis. N Engl J Med 2007 Mar 8;356(10):981–984.CrossRefGoogle Scholar
  74. 74.
    Serruys PW, Daemen J. Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis: a nuisance in both bare metal and drug-eluting stents. Circulation 2007;115:1433–1439.PubMedCrossRefGoogle Scholar
  75. 75.
    Mauri L, Hsieh WH, Massaro JM, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007;356:1020–1029.PubMedCrossRefGoogle Scholar
  76. 76.
    Stone GW, Ellis SG, Colombo A, Dawkins KD, Grube E, Cutlip DE, Friedman M, Baim DS, Koglin J. Offsetting impact of thrombosis and restenosis on the occurrence of death and myocardial infarction after paclitaxel-eluting and bare metal stent implantation. Circulation 2007 Jun 5;115(22):2842–2847.PubMedCrossRefGoogle Scholar
  77. 77.
    Eisenstein EL, Anstrom KJ, Kong DF, et al. Clopidogrel use and long-term clinical outcomes after drug-eluting stent implantation. JAMA 2007;297:159–168.PubMedCrossRefGoogle Scholar
  78. 78.
    Grines CL, Bonow RO, Casey DE, et al. Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents: a science advisory. J Am Coll Cardiol 2007;49:734–739.PubMedCrossRefGoogle Scholar
  79. 79.
    Serruys PW, Daemen J. Are drug-eluting stents associated with a higher rate of late thrombosis than bare metal stents? Late stent thrombosis: a nuisance in both bare metal and drug-eluting stents. Circulation 2007;115:1433–1439.PubMedCrossRefGoogle Scholar
  80. 80.
    Tamai H, Igaki K, Tsuji T, et al. A biodegradable poly-l-lactic acid coronary stent in porcine coronary artery. J Interv Cardiol 1999;12:443–450.CrossRefGoogle Scholar
  81. 81.
    Ormiston J, Serruys PW, Regar E, et al. A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial. Lancet 2008;371:899–907.PubMedCrossRefGoogle Scholar
  82. 82.
    Kornowski R, Hong MK, Tio FO, Bramwell O, Wu H, Leon MB. In-stent restenosis: contributions of inflammatory responses and arterial injury to neointimal hyperplasia. J Am Coll Cardiol 1998;31:224–230.PubMedCrossRefGoogle Scholar
  83. 83.
    Whelan DM, van der Giessen WJ, Krabbendam SC, van Vliet EA, Verdouw PD, Serruys PW, van Beusekom HM. Biocompatibility of phosphorylcholine coated stents in normal porcine coronary arteries. Heart 2000;83:338–345.PubMedCrossRefGoogle Scholar
  84. 84.
    Passamani E, Davis KB, Gillespie MJ, et al. A randomized trial of coronary artery bypass surgery: Survival of patients with a low ejection fraction. N Engl J Med 1985;312:1665–1671.PubMedCrossRefGoogle Scholar
  85. 85.
    Scott SM, Luchi RJ, Deupree RH, et al. Veterans Administration cooperative srudy for the treatment of patients with unstable angina: Results in patients with abnormal left ventricular function. Circulation 1988;78(suppl I):I-113–I-121.Google Scholar
  86. 86.
    Naunheim KS, Fiore AC, Wadley JJ, et al. The changing profile of the patient undergoing coronary artery bypass surgery. J Am Coll Cardiol 1988;11:494–498.PubMedCrossRefGoogle Scholar
  87. 87.
    Kennedy JW, Kaiser GC, Fisher LD, et al. Multivariate discriminant analysis of the clinical and angiographic predictors of operative mortality form the collaborative study in coronary artery surgery (CASS). J Thorac Cardiovasc Surg 1980;80:876–887.PubMedGoogle Scholar
  88. 88.
    Luu M, Stevenson LW, Brunken RC, et al. Delayed recovery of revascularized myocardium after referral for cardiac transplantation. Am Heart J 1990;119:668–670.PubMedCrossRefGoogle Scholar
  89. 89.
    Tillisch J, Brunken R, Marshall R, et al. Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N Engl J Med 1986;314: 884–888.PubMedCrossRefGoogle Scholar
  90. 90.
    Allman KC, Shaw LJ, Hachamovitch R, Udelson J. Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta analysis. J Am Coll Cardiol 2002;39:1151–1158.PubMedCrossRefGoogle Scholar
  91. 91.
    Veenhuyzen GD, Sing SN, McAreavey D, et al. Prior coronary artery bypass surgery and risk of death among patients with ischemic left ventricular dysfunction. Circulation 2001;104:1489–1493.PubMedCrossRefGoogle Scholar
  92. 92.
    Stevens T, Kahn JK, McCallister BD, et al. Safety and efficacy of percutaneous transluminal coronary angioplasty in patients with left ventricular dysfunction. Am J Cardiol 1991;68:313–319.PubMedCrossRefGoogle Scholar
  93. 93.
    Holmes DR, Kip KE, Kelsey SF, et al. Cause of death analysis in the NHLBI PTCA registry: results and considerations for evaluating long-term survival after coronary interventions. J Am Coll Cardiol 1997;30:881–887.PubMedCrossRefGoogle Scholar
  94. 94.
    Toda K, Mackenzie K, Mehra MR, DiCorte CJ, Davis JE, McFadden PM, Ochsner JL, White C, Van Meter CH Jr;. Revascularization in severe ventricular dysfunction (15% < OR = LVEF < OR = 30%): a comparison of bypass grafting and percutaneous intervention. Ann Thorac Surg. 2002 Dec;74(6):2082–7.Google Scholar

Copyright information

© Springer-Verlag London 2009

Authors and Affiliations

  1. 1.Department of Internal Medicine-CardiologyMedical School Houston, University of TexasHoustonUSA

Personalised recommendations